Zoldonrasib (RMC-9805) is a mutant-selective covalent KRAS G12D inhibitor with oral activity and significant antitumor activity, inducing tumor cell apoptosis in preclinical models of various KRAS-mutant cancers.
Molecular Weight:
1168.44
Purity:
98.10%
CAS Number:
[2922732-54-3]
Formula:
C63H88F3N11O7
Target:
Apoptosis|||Kras|||Ras
T78212
T78212
* VAT and and shipping costs not included. Errors and price changes excepted